SHINE Medical Technologies, LLC
Dedicated to being the world’s top medical isotope producer
SHINE Medical Technologies is a nuclear technology company committed to the production of diagnostic and therapeutic medical isotopes to supply the global market. The focus of the company’s diagnostic isotope work is solving the global Mo-99 shortage. SHINE also expects to produce I-131, Xe-133, Sr-89, and other isotopes using its LEU fusion-fission process. SHINE’s platform technology eliminates the need for a nuclear reactor, which provides significant advantages over other technologies, including greater efficiencies, improved reliability, and less nuclear waste. The company will produce Mo-99 that is compatible with the existing supply chain, with seamless service, and requires no additional operating costs. SHINE recently established a European office and appointed a leadership team for a second production facility to be located in the region. The company also created SHINE Therapeutics, a division focused initially on the development and commercialization of Lu-177. This isotope has the potential to fundamentally change the way cancer patients are treated. SHINE is located in Wisconsin, USA. For more information, please visit https://shinemed.com/ and stop by our booth.